727
Views
2
CrossRef citations to date
0
Altmetric
Coronavirus

COVID-19 vaccine hesitancy among pregnant women attending public antenatal clinics in Dar es Salaam, Tanzania

, , &
Article: 2269777 | Received 08 May 2023, Accepted 07 Oct 2023, Published online: 09 Nov 2023

References

  • WHO COVID-19 dashboard. COVID-19 updates [Internet]. World Health Organization; 2023 [Accessed 2023 Sep 13]. https://covid19.who.int/.
  • Allotey J, Fernandez S, Bonet M, Stallings E, Yap M, Kew T, Zhou D, Coomar D, Sheikh J, Lawson H, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ [Internet]. 2020 Sep 1; m3320. doi:10.1136/bmj.m3320.
  • Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, Ahabedian J, Anderson K, Gilboa SM. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020. Obstet Gynecol Surv [Internet]. 2020 Nov;75(11):664–10. doi:10.1097/01.ogx.0000721400.07132.fc.
  • Peretz-Machluf R, Hirsh-Yechezkel G, Zaslavsky-Paltiel I, Farhi A, Avisar N, Lerner-Geva L, Meyer R, Tsur A, Yinon Y. Obstetric and neonatal outcomes following COVID-19 vaccination in pregnancy. JCM [Internet]. 2022 Apr 30;11(9):2540. doi:10.3390/jcm11092540.
  • Cruz-Lemini M, Ferriols Perez E, de la Cruz Conty M, Caño Aguilar A, Encinas Pardilla M, Prats Rodríguez P, Muner Hernando M, Forcen Acebal L, Pintado Recarte P, Medina Mallen M, et al. Obstetric outcomes of SARS-CoV-2 infection in asymptomatic pregnant women. Viruses [Internet]. 2021 Jan 15;13(1):112. doi:10.3390/v13010112.
  • DeBolt CA, Bianco A, Limaye MA, Silverstein J, Penfield CA, Roman AS, Rosenberg HM, Ferrara L, Lambert C, Khoury R, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol [Internet]. 2021 May;224(5):.e510.1–.e2. doi:10.1016/j.ajog.2020.11.022.
  • Pathirathna ML, Samarasekara BPP, Dasanayake TS, Saravanakumar P, Weerasekara I. Adverse perinatal outcomes in COVID-19 infected pregnant women: a systematic review and meta-analysis. Healthcare [Internet]. 2022 Jan 20;10(2):203. doi:10.3390/healthcare10020203.
  • Leduc D, Senikas V, Lalonde AB, Leduc D, Ballerman C, Biringer A, Delaney M, Duperron L, Girard I, Jones D, et al. CLINICAL PRACTICE OBSTETRICS COMMITTEE. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can [Internet]. 2009;31(10):980–93. http://www.ncbi.nlm.nih.gov/pubmed/19941729.
  • Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. Can Med Assoc J [Internet]. 2021 Apr 19; 193(16):E540–8. doi:10.1503/cmaj.202604.
  • Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol [Internet]. 2022 Feb;226(2):177–86. doi:10.1016/j.ajog.2021.08.054.
  • Rahmati M, Koyanagi A, Banitalebi E, Yon DK, Lee SW, Il Shin J, Smith L. The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: a systematic review and meta-analysis. J Med Virol [Internet]. 2023;95(1). doi:10.1002/jmv.28325.
  • Rahmati M, Yon DK, Lee SW, Soysal P, Koyanagi A, Jacob L, Li Y, Park JM, Kim YW, Shin JI, et al. New‐onset neurodegenerative diseases as long‐term sequelae of SARS‐CoV‐2 infection: a systematic review and meta‐analysis. J Med Virol [Internet]. 2023 Jul 2;95(7). doi:10.1002/jmv.28909.
  • Rahmati M, Yon DK, Lee SW, Udeh R, McEvoy M, Kim MS, Gyasi RM, Oh H, López Sánchez GF, Jacob L, et al. New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: a systematic review and meta‐analysis of cohort studies. J Med Virol [Internet]. 2023 Jun;95(6). doi:10.1002/jmv.28833.
  • WHO. DRAFT landscape of COVID-19 candidate vaccines. 2020 Dec [Accessed 2021 Oct]. https://www.who.int/publications/m/item/draft/landscape-of-covid-19-candidate-vaccines.
  • Hagrass AI, Almadhoon HW, Al M, Almaghary BK, Nourelden AZ, Fathallah AH, Hasan MT, Mohammed YA, Al-Nabahin AO, Wafi DS, et al. Maternal and neonatal safety outcomes after SAR ‑ CoV ‑ 2 vaccination during pregnancy: a systematic review and meta ‑ analysis. BMC Pregnancy Childbirth [Internet]. 2022;22:1–19. doi:https://doi.org/10.1186/s12884-022-04884-9.
  • Rahmati M, Yon DK, Lee SW, Butler L, Koyanagi A, Jacob L, Shin JI, Smith L. Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: a systematic review and meta-analysis. Rev Med Virol [Internet]. 2023 May;33(3):e2434. doi:10.1002/rmv.2434.
  • Nir O, Schwartz A, Toussia-Cohen S, Leibovitch L, Strauss T, Asraf K, Doolman R, Sharabi S, Cohen C, Lustig Y, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM [Internet]. 2022 Jan;4(1):100492. doi:10.1016/j.ajogmf.2021.100492.
  • EMA. COVID-19 vaccine safety update [Internet]. 2021 Jan:1–4. https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-comirnaty-january-2021_en.pdf.
  • Sarwal Y, Sarwal T, Sarwal R. Prioritizing pregnant women for COVID-19 vaccination [Internet]. Int J Gynecol Obstet [Internet]. 2021;155:57–63. doi:10.1002/ijgo.13816.
  • Goodman T Update on WHO Interim recommendations on COVID-19 vaccination of pregnant and lactating women [ PowerPoint presentation]. World Heal Organ; 2021.
  • CDC. COVID-19 vaccination during pregnancy. 2022. https://www.cdc.gov/coronavirus/2019-ncov/downloads/vaccines/covid-19-vaccination-during-pregnancy.pdf.
  • AGOTA. Statement on COVID-19 vaccination of pregnant and lactating women. 2021;1–5.
  • Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu J, Boyce TG, Daley MF, Fuller CC, Getahun D, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth — eight Integrated health care organizations, United States, December 15, 2020–July 22, 2021. MMWR Morb Mortal Wkly Rep [Internet]. 2022 Jan 7;71(1):26–30. doi:10.15585/mmwr.mm7101e1.
  • Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, Marquez PL, Olson CK, Liu R, Chang KT, et al. Preliminary findings of mRNA covid-19 vaccine safety in pregnant persons. N Engl J Med [Internet]. 2021 Jun 17;384(24):2273–82. doi:10.1056/NEJMoa2104983.
  • Naqvi S, Naqvi F, Saleem S, Thorsten VR, Figueroa L, Mazariegos M, Garces A, Patel A, Das P, Kavi A, et al. Health care in pregnancy during the COVID-19 pandemic and pregnancy outcomes in six low- and-middle-income countries: evidence from a prospective, observational registry of the global network for women’s and children’s health. BJOG An Int J Obstet Gynaecol [Internet]. 2022 Jul 20;129(8):1298–307. doi:10.1111/1471-0528.17175.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine [Internet]. 2015 Aug;33(34):4161–4. doi:10.1016/j.vaccine.2015.04.036.
  • Domek GJ, O’Leary ST, Bull S, Bronsert M, Contreras-Roldan IL, Bolaños Ventura GA, Kempe A, Asturias EJ. Measuring vaccine hesitancy: field testing the WHO SAGE working group on vaccine hesitancy survey tool in Guatemala. Vaccine. 2018 Aug;36(35):5273–81. doi:10.1016/j.vaccine.2018.07.046.
  • Biswas MR, Alzubaidi MS, Shah U, Abd-Alrazaq AA, Shah Z. A scoping review to find out worldwide COVID-19 vaccine hesitancy and its underlying determinants. Vaccines. 2021 Oct 25;9(11):1243. doi:10.3390/vaccines9111243.
  • Nguyen LH, Hoang MT, Nguyen LD, Ninh LT, Nguyen HTT, Nguyen AD, Vu LG, Vu GT, Doan LP, Latkin CA, et al. Acceptance and willingness to pay for COVID‐19 vaccines among pregnant women in Vietnam. Trop Med Int Heal [Internet]. 2021 Oct 23;26(10):1303–13. doi:10.1111/tmi.13666.
  • Marzo RR, Ahmad A, Islam MS, Essar MY, Heidler P, King I, Thiyagarajan A, Jermsittiparsert K, Songwathana K, Younus DA, et al. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: a global survey of 20 countries. Van Weyenbergh J, editor. PLoS Negl Trop Dis [Internet]. 2022 Jan 28;16(1):e0010103. doi:http://dx.doi.org/10.1371/journal.pntd.0010103.
  • Piltch-Loeb R, Silver DR, Kim Y, Norris H, McNeill E, Abramson DM. Determinants of the COVID-19 vaccine hesitancy spectrum. Rosenbaum JE, editor. PLoS One [Internet]. 2022 Jun 1;17(6):e0267734. doi:10.1371/journal.pone.0267734.
  • Hossain MB, Alam Z, Islam S, Sultan S, Faysal M, Rima S, Hossain MA, Al Mamun A. Health Belief, planned behavior, or psychological antecedents: what predicts COVID-19 vaccine hesitancy better among the Bangladeshi adults? This study aimed to determine the prevalence and investigate the constellations of psychological determinants. 2021.
  • Jayagobi P, Ong C, Thai YK, Lim CC, Jiun SM, Koon KL, Wai KC, Chan JK, Mathur M, Chien CM. Perceptions and acceptance of COVID-19 vaccine among pregnant and lactating women in Singapore: a cross-sectional study. 2021;19.
  • Mose A, Yeshaneh A. COVID-19 vaccine acceptance and its associated factors among pregnant women attending antenatal care clinic in Southwest Ethiopia: Institutional-based cross-sectional study. Int J Gen Med [Internet]. 2021 Jun;14:2385–95.doi:10.2147/IJGM.S314346.
  • Kalam MA, Davis TP, Shano S, Uddin MN, Islam MA, Kanwagi R, Islam A, Hassan MM, Larson HJ. Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: implications for behavior change interventions. Metwally AM, editor. PLoS One [Internet]. 2021 Aug 23;16(8):e0256496. doi:10.1371/journal.pone.0256496.
  • Khairat S, Zou B, Adler-Milstein J. Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US. Am J Infect Control. 2022;50(3):262–7. doi:10.1016/j.ajic.2021.12.013.
  • Goncu Ayhan S, Oluklu D, Atalay A, Menekse Beser D, Tanacan A, Moraloglu Tekin O, Sahin D. COVID‐19 vaccine acceptance in pregnant women. Int J Gynecol Obstet [Internet]. 2021 Aug;154(2):291–6. doi:10.1002/ijgo.13713.
  • Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, Wu JW. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol [Internet]. 2021;36(2):197–211. doi:10.1007/s10654-021-00728-6.
  • Tarimo CS, Wu J. The first confirmed case of COVID-19 in Tanzania: recommendations based on lesson learned from China. Trop Med Health. 2020;48(1):2. doi:10.1186/s41182-020-00214-x.
  • MoH. Guideline for COVID-19 vaccination. 2021 July;1–54. https:www.eahealth.org/sites/www.eahealth.org/files/content/attachments/2021-08-02/final/guidelines/For/COVID-19/Vaccine.
  • de Miguel-Arribas A, Aleta A, Moreno Y. Impact of vaccine hesitancy on secondary COVID-19 outbreaks in the US: an age-structured SIR model. BMC Infect Dis [Internet]. 2022 Jun 1;22(1):511. doi:10.1186/s12879-022-07486-0.
  • Olivera Mesa D, Hogan AB, Watson OJ, Charles GD, Hauck K, Ghani AC, Winskill P. Modelling the impact of vaccine hesitancy in prolonging the need for non-pharmaceutical interventions to control the COVID-19 pandemic. Commun Med [Internet]. 2022 Feb 10;2(1):14. doi:10.1038/s43856-022-00075-x.
  • MoH. Weekly trend of COVID-19 situation report in Tanzania [Internet]. 2022 [accessed 2022 Jul 24]. 1–7. https://www.moh.go.tz/storage/app/uploads/public/629/5ce/837/6295ce8370a3d468651045.pdf.
  • Davis TP, Yimam AK, Kalam MA, Tolossa AD, Kanwagi R, Bauler S, Kulathungam L, Larson H. Behavioural determinants of COVID-19-Vaccine acceptance in rural areas of six lower- and middle-income countries. Vaccines. 2022 Jan 29;10(2):214. doi:10.3390/vaccines10020214.
  • Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, Ng RWY, Lai CKC, Boon SS, Lau JTF, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. 2021 Feb;39(7):1148–56. doi:10.1016/j.vaccine.2020.12.083.
  • Cai Z, Hu W, Zheng S, Wen X, Wu K. Cognition and behavior of COVID-19 vaccination based on the health Belief model: a cross-sectional study. Vaccines. 2022 Apr 1;10(4):544. doi:10.3390/vaccines10040544.
  • Macrotrends. Tanzania Metro area population 1950-2023 [Internet]. Dar es Salaam; 2023. [accessed 2023 Jan 20]. https://www.macrotrends.net/cities/22894/dar-es-salaam/population.
  • MoH. Weekly trend of COVID-19 confirmed cases in Tanzania. 2022 [Accessed 2022 Jun 20]. 27:1–7.https://www.moh.go.tz/storage/app/uploads/publics/623/bf6/9a3/623bf69a3d819268181372.
  • Bishaw Z, Id A, Bogale TW, Bantie GM, Ayalew F, Tamir W. Factors associated with willingness to take COVID-19 vaccine among pregnant women at. PLoS One [Internet]. 2022;1–17. doi:10.1371/journal.pone.0276763.
  • Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med [Internet]. 2021 Aug 16;27(8):1385–94. doi:10.1038/s41591-021-01454-y.
  • Jayagobi PA, Ong C, Thai YK, Lim CCW, Jiun SM, Koon KL, Wai KC, Chan JK, Mathur M, Chien CM. Perceptions and acceptance of COVID-19 vaccine among pregnant and lactating women in Singapore: a cross-sectional study. medRxiv [Internet]. 2021;19. 2021.06.29.21259741. http://medrxiv.org/content/early/2021/07/04/2021.06.29.21259741.abstract.
  • Maximillian biyemo vicent fabiola. Predictors for the uptake of tetanus toxoid vaccination during pregnancy among women of reproductive age in Tanzania. 2020.
  • Osur JO, Chengo R, Muinga E, Kemboi J, Sidibe M, Rarieya M. Determinants of COVID ‑ 19 vaccine behaviour intentions among the youth in Kenya: a cross ‑ sectional study. Arch Public Heal [Internet]. 2022;80:1–13. doi:https://doi.org/10.1186/s13690-022-00904-4.
  • Hailemariam S, Mekonnen B, Shifera N, Endalkachew B, Asnake M, Assefa A, Qanche Q. Predictors of pregnant women ’ s intention to vaccinate against coronavirus disease 2019: a facility-based cross-sectional study in southwest Ethiopia. SAGE Open Med. 2021;9:205031212110384. doi:10.1177/20503121211038454.
  • King WC, Rubinstein M, Reinhart A, Mejia R. COVID-19 vaccine hesitancy January-May 2021 among 18 – 64 year old US adults by employment and occupation. Prev Med Rep [Internet]. 2021;24(August):101569. doi:10.1016/j.pmedr.2021.101569.
  • Takahashi S, Takahashi N, Sasaki S, Nohara M, Kawachi I. SSM - Population health occupational disparities in COVID-19 vaccine hesitancy in Japan. SSM - Popul Heal [Internet]. 2022;19(July):101226. doi:10.1016/j.ssmph.2022.101226.
  • Mahmoud M, Alanazi M, Albarrak MS, Aljarba K, Almutairi NG. The percentage of vaccine hesitancy among Married individuals in times of the COVID-19 pandemic: a cross sectional study in Riyadh city. Kingdom Saudi Arabia. 2022;2:20–6. doi:10.1159/000520681.
  • Naqvi S, Saleem S, Naqvi F, Billah SM, Nielsen E, Fogleman E, Peres‐da‐Silva N, Figueroa L, Mazariegos M, Garces AL, et al. Knowledge, attitudes, and practices of pregnant women regarding COVID‐19 vaccination in pregnancy in 7 low‐ and middle‐income countries: an observational trial from the global network for women and children’s health research. BJOG An Int J Obstet Gynaecol [Internet]. 2022 Nov 5;129(12):2002–9. doi:10.1111/1471-0528.17226.
  • H A. Why Africa fears western medicine. The New Work Times [Internet]. 2007;1–3. http://www.nytimes.com/2007/07/31/opinion/31washington.html?_r=1&oref=slogin.